ArticleCell communication and signaling : CCS2021

Inhibition of mutant KRAS-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancer.

Ari Hashimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.